Zomato gets over $100 million from Tiger Global – valuation could hit $3.4 billion
- The company has raised $102.5 million at a $3.4 billion valuation, reported Entrackr.
- With the latest investment, Zomato has raised $319.5 million in 2020 so far.
- The food tech unicorn’s funding will also help it gather steam to fight against its Indian rival Swiggy and the likes of Amazon entering the market.
AdvertisementIndian food tech unicorn Zomato has received fresh funds from Tiger Global Management. The company has raised $102.5 million at a $3.4 billion valuation, reported Entrackr.
However, recently analysts at HSBC had valued the startup at $5 billion.
With the latest investment, Zomato has raised over $319.5 million in 2020 so far. Zomato has not released an official statement as of yet. This comes at a time when the company’s operations have been hit by the coronavirus pandemic.
Zomato: Fundraising in 2020
|Tiger Global||$102.5 million|
|Pacific Horizon Investment Trust||$5 million|
|Ant Financial||$150 million|
In the first quarter of FY21, with most restaurants being shut and operating on a takeaway only business, Zomato reported a revenue of $41 million and loss of $12 million. “In terms of the size of the business, COVID-19 has set us back by a year or so – but a year is only a small blip when you are building a company for the next 100 years,” wrote Zomato CEO Deepinder Goyal in an earlier blog.
Zomato had laid off 1300 employees due to the pandemic. Goyal said that he dreads that 40% of their restaurants will shut down because of the pandemic.
The foodtech unicorn’s funding will also help it gather steam to fight against its Indian rival Swiggy and the likes of Amazon entering the food delivery market.
Yatra's failed merger with Ebix dents the company's earnings in an already troubled quarter
Popular on BI
- ‘Padman of 2022’: Shark Peyush Bansal offers founder of women’s hygiene startup PadCare a blank cheque
- Gautam Adani lost $52 billion in 6 days. That's over 3 times what Sam Bankman-Fried lost in a similar timeframe.
- A 45-year-old biotech CEO may have reduced his biological age by at least 5 years through a rigorous medical program that can cost up to $2 million a year, Bloomberg reported
- Revival of rural economy to take time in the absence of triggers: JM Financial
- Logistics startup FarEye lays off 90 employees, 2nd job cut in 8 months
- Vani Jayaram, the voice behind 10,000 songs, passes away at 78
- Not the first time FPO is taken back, won't affect image of the country: FM
- India's cancer cases will surge to 20 lakh per year by 2026: AIIMS